Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice

Affiliations

• ¹ Policy Analysis Inc. (PAI), Brookline, Massachusetts, United States.
• ² Bristol-Myers Squibb, Lawrenceville, New Jersey, United States.
• ³ Pfizer Inc., New York, New York, United States.
• ⁴ Pfizer Inc., Groton, Connecticut, United States.
• ⁵ Bristol-Myers Squibb, Wallingford, Connecticut, United States.
• ⁶ Guy's and St. Thomas' Hospitals, London, United Kingdom.